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Abstract
Background: Obstructive sleep apnea (OSA) is a low-grade inflammatory disease affecting the cardiovascular and metabolic
systems. Increasing OSA severity reduces T-regulatory lymphocytes (Tregs) in OSA children. Since Tregs modulate
endothelial activation, and attenuate insulin resistance, we hypothesized that Tregs are associated with endothelial and
metabolic dysfunction in pediatric OSA.
Methods: 50 consecutively recruited children (ages 4.8–12 years) underwent overnight polysomnography and fasting
homeostatic model (HOMA) of insulin resistance was assessed. Percentage of Tregs using flow cytometry, and endothelial
function, expressed as the time to peak occlusive hyperemia (Tmax), were examined. In a subgroup of children (n = 21),
in vitro Treg suppression tests were performed.
Results: Circulating Tregs were not significantly associated with either BMI z score or HOMA. However, a significant inverse
correlation between percentage of Tregs and Tmax emerged (p,0.0001, r =20.56). A significant negative correlation
between Tregs suppression and the sleep pressure score (SPS), a surrogate measure of sleep fragmentation emerged
(p = 0.02, r =20.51) emerged, but was not present with AHI.
Conclusions: Endothelial function, but not insulin resistance, in OSA children is strongly associated with circulating Tregs
and their suppressive function, and appears to correlate with sleep fragmentation. Thus, alterations in T cell lymphocytes
may contribute to cardiovascular morbidity in pediatric OSA.
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Introduction
Obstructive sleep apnea (OSA) is characterized by changes in
intrathoracic pressure, intermittent hypoxia, hypercapnia and
sleep fragmentation. These changes result in sympathetic alter-
ations, increased systemic oxidative stress and the activation of
inflammatory processes, all of which likely play important roles in
mediating the cardiovascular and metabolic morbidities of OSA
[1–3].
In adults, longitudinal studies have shown that severe OSA is
associated with higher cardiovascular mortality, cardiovascular
risk increases in a stepwise fashion with corresponding severity of
OSA, and treatment with CPAP reduces both fatal and non-fatal
cardiovascular events [4]. Cardiovascular complications have also
been described in children with OSA, and include disturbances in
blood pressure regulation, ventricular remodeling, and endothelial
dysfunction [5]. Endothelial dysfunction is thought to predispose
to atherosclerosis and increased cardiovascular risk. Post-occlusive
hyperemic response testing has revealed significant impairments in
endothelial function among children with OSA when compared to
controls, with the majority of these children showing significant
improvements in endothelial function after treatment of OSA with
adenotonsillectomy [6]. In addition, both obesity and OSA can
independently increase the risk of developing endothelial dysfunc-
tion, and the concurrent presence of both conditions markedly
increases this risk [7,8]. Markers of inflammation and vascular
injury such as adhesion molecules, circulating microparticles and
myeloid-related protein 8/14 are all more likely to be increased in
children with OSA, and are strongly associated with the presence
of endothelial dysfunction [9–11]. However, at any given level of
OSA severity, not all children with OSA have endothelial
dysfunction as assessed by post-occlusive hyperemic responses,
suggesting that individual factors underlying the immune response
could be responsible for the discrepant vascular manifestations of
OSA in children.
Similar to cardiovascular involvement, children with OSA
appear to be at increased risk for developing metabolic syndrome
[12]. Insulin resistance and alterations in lipid homeostasis have
now repeatedly been described in children with OSA, particularly
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in those who are obese, and inflammatory networks are associated
with the degree of metabolic derangement [13,14].
Most of the research efforts exploring the inflammatory
pathways involved in OSA have concentrated on pro- inflamma-
tory immune cells such as monocytes/macrophages and cytotoxic
lymphocytes. However, immune homeostasis involves a delicate
balance between pro- and anti- inflammatory elements that are
tightly regulated, such that reduction in specific anti-inflammatory
populations could potentiate inflammation. We have recently
reported that increasing OSA severity is associated with a
reciprocal decrease in the percentage of T regulatory lymphocytes
(Tregs) in the peripheral blood of children with OSA [15]. T regs
are a subpopulation of T lymphocytes specialized in immune
suppression, that are characterized by their surface markers CD4
and CD25 and expression of the transcription factor Forkhead box
protein P3 (FOXP3) [16]. Tregs are critical against inappropriate
immune responses, and disruption of their differentiation or
function can result in autoimmunity, allergy, inflammation and
tumorigenesis [16]. In recent years,
Tregs have been shown to inhibit development and progression
of atherosclerosis [17], and affect multiple critical pathways
involved in obesity and glucose homeostasis [18–20].
Based on aforementioned considerations, we hypothesized that
the decrease in Tregs seen in children with OSA contributes to the
pathogenesis of endothelial and metabolic dysfunction in the
disease. We therefore aimed to determine whether significant
associations occur between percentage of circulating Tregs and
measures of endothelial and metabolic function, i.e., the post-
occlusive hyperemic response and the homeostatic model of
insulin resistance.
Methods
Subjects were recruited from the Sleep and ENT clinics of
Kosair Children’s Hospital (Louisville) and Comer Children’s
Hospital (Chicago), as well as by advertisement. Patients who had
genetic or craniofacial syndromes and any chronic diseases such as
cardiac disease, diabetes, cerebral palsy and chronic lung disease
of prematurity were excluded. The research protocol was
approved by the University of Louisville (protocol #474.99) and
University of Chicago (protocol 09-115-B) human research ethics
committees and written informed consent was obtained from the
parents, with assent being obtained from the children.
50 subjects were consecutively recruited, 22 from Louisville, 28
from Chicago. They underwent a standard overnight polysomno-
graphy (PSG) as previously described [21], which was scored as
per the 2007 American Association of Sleep Medicine guidelines
for the scoring of sleep and associated events [22]. The sleep
pressure score (SPS), a measure of OSA-induced sleep fragmen-
tation, was calculated using the following equation [23]:
SPS = RAI/ARtotI * (1 - SAI/ARtotI) where RAI is the
respiratory arousal index, SAI is spontaneous arousal index,
ARtotI is the total arousal index.
Height was measured with a stadiometer and recorded to the
nearest 0.1 cm. Weight was recorded to the nearest 0.1 kg. Height
and weight centiles were calculated using the Centre for Disease
Control 2000 growth charts for the United States. BMI z-scores
were calculated using The Children’s Hospital of Philadelphia
BMI and z-score calculation in children online software (http://
stokes.chop.edu/web/zscore).
A fasting blood sample was taken the following morning.
Fasting insulin and glucose levels were assayed by the clinical
biochemistry laboratory at The University of Chicago Medical
Centre. The homeostatic model (HOMA) was calculated using the
HOMA calculator software from the University of Oxford as a
measure of insulin resistance. The percentage of Tregs was
examined using flow cytometry using a Beckman-Coulter Gallios
flow cytometer (Beckman Coulter Inc, IL, USA) as described in a
previous study [15]. Tregs were defined as cells which were
CD4+CD25+ and FOXP3+.
Endothelial function was assessed using a modified hyperemic
test as previously described [24]. In brief, this involves occlusion of
the radial and ulnar arteries using a blood pressure cuff applied to
the forearm. A laser Doppler sensor (Periflux 5000 System
integrated with the PF 5050 Pressure Unit, Perimed; Ja¨rfa¨lla,
Sweden) was applied over the volar aspect of the hand at the distal
metacarpal surface of the first finger and the hand was gently
immobilized. Tests were performed on awakening in the morning
and children were in a fasted state. They lay supine with the head
of the couch at 45u. The cuff was connected to a computer
controlled manometer and the pressure was raised to 200 mmHg
for 60seconds during which blood flow was reduced to undetect-
able levels. The cuff was then deflated via computer controlled
pressure release to allow for consistent deflation times. Hyperemic
responses were measured using the laser Doppler device.
Commercially available software (Perimed; Ja¨rfa¨lla, Sweden) was
used to calculate the time to peak regional blood flow post
occlusion release (Tmax), a measure of the postocclusion
hyperemic response, an index of endothelial function.
T cell suppression tests [25] were performed in a subgroup of
children (n = 21) where sufficient blood was available.
CD4+CD25+ and CD4+CD25- cells were first isolated using the
RosetteSepH Human CD4+ T Cell Enrichment Cocktail (Stemcell
technologies, cat no. #15062) and EasySepH CD25+ Positive
Selection Cocktail (Stemcell technologies Human CD25 Positive
Selection Kit Catalogue #18231) as per the manufacturers
instructions [23]. The purity of the CD4+CD25+ and
CD4+CD25- cells was consistently .90%. The CD4+CD25- cells
were stained with CFSE CellTraceTM CFSE Cell Proliferation
Kit (Molecular probes C34554) for 5 min at room temperature.
Staining was quenched with 10 ml PBS with 5%FBS and the cells
washed. CD4+CD25+ Tregs were co-cultured with these
CD4+CD25- effector cells at varying concentrations [1:1 (Treg:-
Teffector), 1:2, 1:4 and just CD4+CD25- cells T effector cells] in a
96 well roundbottom plate (30 000 effector cells per well). 2 ml
DynabeadsH Human T-Activator CD3/CD28 for Cell Expansion
and Activation (Invitrogen cat. no 111-61D) was added to each
well. The cells were incubated at 37uC for 4 days in RPMI 1640
medium (Sigma Aldrich), containing 10%FBS, 1 mM sodium
pyruvate, 0.3 g/l L-glutamine and Penicillin/streptamycin) and
were then analysed using flow cytometry. An example is shown in
Figure 1. Treg suppression function was expressed as percentage
suppression, calculated using the following equation: 1-(DI 1:1
ratio/DI only CD4+CD25- effector cells)X100%, DI being the
division index, the average number of divisions for all the cells in
the original starting population, as calculated using FlowJo
software (Treestar Inc, USA). The different ratios were performed
to ensure that a dose dependent effect was seen for each sample.
Data Analysis
Statistical analysis was performed using Graphpad Prism
version 5.0 (Graphpad software Inc, CA, USA). When data were
normally distributed, they are expressed as mean 6 standard
deviation and the unpaired t test was used to compare differences
between the 2 groups. When data were not normally distributed,
they are expressed as median (interquartile range), and the non-
parametric Mann Whitney test was used. Categorical data were
analyzed using the Chi square test. As T max and SPS data were
T Regulatory Cells, Endothelial Function and OSA
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not normally distributed, non-parametric Spearman’s correlation
was used for the calculation of r and p values.
Results
50 subjects were consecutively recruited. They were divided into
2 groups based on their PSG results: controls who had an
OAHI,1 (n = 13) and children with OSA (OAHI$1) (n = 37).
Their clinical characteristics and PSG results are summarized in
Table 1. The 2 groups were no different with regards to their age,
gender, ethnicity and BMI. As expected, the OSA group had a
shorter sleep onset latency, spent a shorter period of time in REM
sleep, had a higher respiratory arousal index, higher apnea
hypopnea index, lower oxygen saturation nadir and spent a higher
percentage of time with end tidal CO2.45 mmHg. Children with
OSA had a lower percentage of Tregs compared to controls
([mean6SD] [(6.562.0) vs. (7.861.1) p = 0.03) (Figure 2a). The
Tmax of children with OSA was [median(interquartile
range)27.5(8.4–39.3)] seconds as compared to 19.0(14.2–23.1)sec-
onds in controls. There was a high degree of variance in the OSA
patients (Figure 2b).
Circulating Tregs were not significantly associated with either
BMI z score or with HOMA, but were associated with AHI
(p,0.01; r: 20.42). However, a strong and highly significant
inverse correlation between percentage of Tregs and Tmax
emerged (p,0.0001, r =20.56) (Figure 3a). The lower the
percentage of Tregs, the longer it took to reach the peak regional
blood flow post occlusion release, implying that children with
endothelial dysfunction had lower percentage of Tregs. As
expected, HOMA correlated with BMI (p = 0.0003, r = 0.64)
(Figure 3b) and obese children had higher insulin resistance. There
was no relationship between HOMA and T max (Figure 3c)
suggesting that children with insulin resistance do not necessarily
have endothelial dysfunction, and therefore, the pathological
mechanisms for metabolic impairment and vascular endothelial
impairment may be different.
In the subgroup of children who had Treg suppression tests
performed, there was no significant correlation between Treg
suppressive ability and AHI (Figure 4a). However, a significant
negative association between percentage suppression of T
lymphocyte proliferation by Tregs and the SPS emerged
(p = 0.02, r =20.51) (Figure 4b).
Discussion
To the best of our knowledge, this is the first study to indicate
that decreased circulating Tregs are associated with endothelial
dysfunction in pediatric OSA. When combined with previous data
which showed that the degree of decrease in circulating Tregs in
children was related to the clinical severity of their OSA, it raises
the possibility that the decrease in Tregs may in part mediate the
endothelial dysfunction that occurs in a subset of children with
OSA. Importantly, this effect appears to be tissue specific, as there
is no correlation of Tregs with insulin resistance, confirming the
specificity of the former association. The strong association
between Tregs suppressive capacity and SPS, but not AHI,
suggests that sleep fragmentation rather than intermittent hypoxia
may be the primary perturbation affecting Tregs.
The SPS was proposed as a more reliable index of sleep
disruption in snoring children than the total arousal index
(ARtotI). Tauman et al showed that in a cohort of 559 children,
the ARtotI and RAI correlated positively with the AHI [23]. In
Figure 1. Illustrative examples of Treg immune suppression tests. a. Example of T suppression test whereby the Tregs display normal
suppressive function. The graphs show proliferation of the effector cells when no Tregs have been added, proliferation of the effector cells when
Tregs have been added in a 1:1 ratio and proliferation of the effector cells when Tregs have been added in a 1:2 ratio. b. Example of T suppression
test where the Tregs show poor suppression of effector cell proliferation.
doi:10.1371/journal.pone.0069710.g001
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contrast, the SAI showed an inverse relationship with AHI,
possibly because compensatory mechanisms aiming to preserve
sleep homeostasis lead to a decline in spontaneous arousals that
partially compensate for the reciprocal increase in respiratory
arousals. An algorithm incorporating all 3 arousal indices, the
SPS, was therefore proposed as a surrogate measure of disrupted
sleep homeostasis. Similar findings were reported in adults [26].
When children with high SPS were compared with children with
low SPS, they were more likely to have deficits in memory,
language abilities, verbal abilities, and some visuospatial functions.
The SPS was associated with deficits in neurobehavioral daytime
functions, independent of respiratory disturbance and hypoxemia,
suggesting a significant role for disturbed sleep homeostasis in
pediatric sleep-disordered breathing [27]. The fact that the
suppressive capacity of Tregs correlates negatively with SPS, but
not with AHI, suggests that sleep fragmentation rather than
intermittent hypoxia may be the mechanism by which the
observed effects on Tregs are mediated.
Tregs have been linked with endothelial dysfunction and
atherosclerosis. Angiotensin II and aldosterone induced blood
pressure elevation, vascular oxidative stress, inflammation and
endothelial dysfunction can be ameliorated by the adoptive
transfer of Tregs [28–30]. The increase in systolic blood pressure,
impaired acetylcholine vasodilatory responses, increased vascular
stiffness, mesenteric artery vascular cell adhesion molecule
expression and aortic macrophage and T cell infiltration seen in
mice which were infused with Angiotensin II or aldosterone for 2
weeks, were all abrogated when these mice received weekly
intravenous infusions of Tregs. IL-10 secreted by Tregs has also
been shown to improve microvascular endothelial function in
hypertensive mice via inhibition of NADPH oxidase [31].
Figure 2. Individual Tregs counts and endothelial function (Tmax) in children with OSA and controls. a. Tregs expressed as percentage
of CD4+ cells, in children with OSA and controls. b. Tmax (time to peak regional blood flow post occlusion release) in children with OSA and controls.
doi:10.1371/journal.pone.0069710.g002
Table 1. Clinical characteristics and PSG findings in the 50 children studied.
Controls (AHI,1; n=13) OSA (AHI$1; n =37) p value
Age (years) 7.061.7 7.761.9 NS
Gender (% male) (n) 54% (7) 57% (21) NS
Ethnicity NS
%African American (n) 54% (7) 57% (21)
%White Caucasian (n) 46% (6) 35% (13)
%Hispanic (n) 0% (0) 5% (2)
%Others (n) 0% (0) 3% (1)
BMI z score 1.560.7 1.361.0 NS
Sleep efficiency (%) 90.163.6 88.065.9 NS
Sleep onset latency (min) 23.0 (17.8–33.3) 14.0 (7.0–20.0) p,0.01
REM latency (min) 137.0645.7 132.4662.7 NS
Stage 1 (%) 4.561.8 6.564.6 NS
Stage 2 (%) 42.464.4 47.068.3 NS
Slow wave sleep (%) 26.362.7 25.867.4 NS
REM sleep (%) 26.865.4 20.866.2 p,0.01
Spontaneous arousal index 10.1 (8.9–11.5) 12.3 (8.3–16.3) NS
Respiratory arousal index 0 (0–0.3) 6.1 (3.1–11.2) p,0.001
Apnea hypopnea index 0.460.4 13.4612.6 P,0.001
Nadir SpO2 (%) 95.7 (92.0–96.8) 87.5 (82.6–90.0) p,0.001
% time with ETCO2.45 mmHg 0 (0–0.6) 3.9 (1.1–9.3) P,0.001
Normally distributed data are expressed as Mean 6 SD; AHI expressed as/hour total sleep time.
Data that are not normally distributed are expressed as Median (interquartile range).
doi:10.1371/journal.pone.0069710.t001
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Endothelial dysfunction is thought to mediate the increased
cardiovascular risk seen in patients with OSA, and contribute to
the development of atherosclerosis [32]. It is now well established
that inflammation plays a key role in the pathogenesis of
atherosclerosis [33]. Tregs have been shown to be powerful
inhibitors of atherosclerosis in several mouse models [34]. The
adoptive transfer of Tregs has been shown to reduce atheroscle-
rotic lesion development and conversely, the depletion of Tregs
aggravates lesion development. Intranasal immunization of
Apoe2/2 mice with an apolipoprotein B-100 fusion protein has
been shown to induce antigen-specific Tregs with resultant
reduction in aortic atherosclerotic lesion development [35]. It is
therefore biologically plausible that the decrease in Tregs seen in
pediatric OSA could result in increased inflammation and
associated endothelial dysfunction, ultimately leading to athero-
genesis.
Tregs have also been linked to obesity and metabolic
dysfunction. Leptin, a key hormonal regulator of appetite and
metabolism, mainly secreted by adipocytes is thought to be the link
between Tregs and obesity [19]. Leptin is a member of the helical
cytokine family and has a similar structure to IL-2 [36], a critical T
lymphocyte proliferation factor. Leptin is capable of modulating T
Figure 3. Scatterplots of measures of endothelial function, Tregs, BMI, and HOMA. a. Negative correlation between Tmax and circulating
Tregs, expressed as percentage of CD4 cells. b. Correlation of BMI with HOMA. c. There was no correlation of Tmax with HOMA. d. There was no
correlation between HOMA and circulating Tregs, expressed as percentage of CD4 cells.
doi:10.1371/journal.pone.0069710.g003
Figure 4. Scatterplots of Tregs suppressive function and 2 polysomnographic measures. a. There was no correlation between
suppressive function of Tregs with AHI. b. Negative correlation between suppressive function of Tregs with the Sleep Pressure Score.
doi:10.1371/journal.pone.0069710.g004
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lymphocyte immune responses, increasing Th1 and suppressing
Th2 cytokine production [37–39]. Freshly isolated Tregs have
been shown to express high amounts of leptin receptor (ObR) and
produce substantial amounts of leptin, that result in an autocrine
inhibitory loop which constrains their further expansion. Neutral-
ization of leptin in vitro led to the proliferation of Tregs which was
IL-2 dependent and FOXP3 expression was also increased [40]. In
lean mice, a unique population of Tregs has been shown to reside
in adipose tissue and their numbers are reduced in insulin resistant
models of obesity [18], where they play a role in the modulation of
metabolic parameters. Depletion of these Tregs by injection of
diphtheria toxin into mice which expressed diphtheria toxin
receptor under the control of FOXP3 transcriptional regulatory
components resulted in the induction of several genes encoding
inflammatory mediators (including TNFa, IL-6 and RANTES)
and the development of insulin resistance. The converse was true
in gain of function experiments when the population of Tregs was
expanded via injection of a recombinant IL-2, IL-2 specific
monoclonal antibody complex [17,18].18 PPAR-c has recently
been shown to be a crucial molecular orchestrator of the
accumulation and phenotype of these visceral adipose tissue Tregs
[41].
Leptin deficient mice that have a mutation in the leptin gene are
overweight, develop severe insulin resistance, and serve as a model
for type 2 diabetes and the metabolic syndrome [42]. Induction of
Tregs in these mice, by oral administration of anti-CD3 antibody
plus b-glucosylceramide, resulted in decreased pancreatic islet cell
hyperplasia, decreased inflammation in adipose tissue and lower
blood glucose levels [17]. Furthermore, Eller et al showed that the
depletion of Tregs in leptin receptor null mice using an anti-CD25
antibody, resulted in increased insulin resistance and impaired
insulin sensitivity [20]. Treg depleted mice had more severe
diabetic nephropathy, and increased inflammatory cells in their
visceral adipose tissue and kidneys compared to leptin receptor
deficient mice that were not depleted of Tregs. Conversely,
adoptive transfer of Tregs into leptin receptor null mice improved
their insulin sensitivity and diabetic nephropathy. Furthermore,
these investigators showed that obese patients with insulin
resistance display significantly decreased natural Tregs, even
though they manifest increased induced Tregs in their visceral
adipose tissue when compared to lean control subjects [20]. This
could explain the previous conflicting data on Tregs in human
visceral adipose tissue of obese patients with and without insulin
resistance compared to lean control subjects [43,44]. Intriguingly,
several of the drugs used to treat type 2 diabetes have now been
shown to also be immunomodulators. For example, metformin
which activates AMP-activated protein kinase (AMPK) and is one
of the most common drugs used to treat type 2 diabetes has been
shown to inhibit T lymphocyte antigen specific recall responses
and the production of Th1 and Th17 cytokines, while upregulat-
ing IL-10 secretion in mouse splenocytes [45].
Our findings are consistent with those of other groups, who
found no difference in circulating Tregs in children who were
obese compared to those who were not [46,47]. However, some
minor differences in gene expression were noted if metabolic
syndrome was present [48]. Furthermore, the data we present in
this study do not support a relationship between circulating Tregs
and insulin resistance in pediatric OSA. A possible explanation is
that OSA-induced effects on circulating Tregs are tissue specific,
and do not involve mechanisms associated with insulin resistance
and metabolic dysfunction, or that longer periods of time are
required for Treg effects on pancreatic beta cell function or
adipose tissue metabolic dysfunction as elicited by OSA. Alterna-
tively, there is growing realization that the Tregs in adipose tissue
have a unique phenotype, different from that of circulating Tregs
[48]. It is conceivable that the effects on insulin resistance are
mediated by the Tregs in visceral adipose tissue, whereas
circulating Tregs play a role in blood vessel endothelial
dysfunction. Studies specifically looking at the effect of OSA on
Tregs in adipose tissue, leptin levels and insulin resistance would
be of clear interest, but are beyond the scope of the current study.
There are some limitations to our study that are worthy of
mention so that our findings can be interpreted in the appropriate
context: Due to ethical considerations, we were unable to study
Tregs in adipose tissues of children. We also performed
immunostaining with the standard antibody panel of CD4,
CD25 and FOXP3 for the identification of Tregs and future
extensive expression profiling with markers such as glucocorticoid
induced tumor necrosis factor receptor (GITR), OX40, killer cell
lectin-like receptor G2, CD45RA, CD45RO and cytotoxic T
lymphocyte antigen 4 (CTLA-4) would be of considerable interest.
Furthermore, the study was cross-sectional, so the putative
associations identified do not necessarily imply causation. None-
theless, if we consider Hill’s viewpoints on ‘‘what circumstances
can we pass from this observed association to a verdict of
causation’’, the data presented in this study fulfill criteria for
strength of association, specificity and biological gradient (dose
response), at the same time that the literature discussed above
suggests biological plausibility and coherence. There is no doubt
that the data from this study are hypothesis generating. Work in
animal models is needed to confirm whether the relationship
between OSA and decrease in Tregs is indeed a causal one, and to
identify the underlying mechanisms of action resulting in vascular
end organ morbidity. It has recently been shown, that children
with OSA with elevated systemic inflammatory markers, were
more likely to have increased DNA methylation of the FOXP3
gene, the unique transcription factor of T regs [49].
It is tempting to speculate that OSA may elicit epigenetic
changes responsible for the decrease in Tregs. The resulting
decrease in immunosuppressive Tregs may in turn lead to a pro-
inflammatory, pro-atherogenic state, a mechanism through which
endothelial dysfunction occurs. Furthermore, there is considerable
overlap between endothelial dysfunction and neurocognitive
deficits in children with OSA [50], and it is not unreasonable to
suggest they may well share similar pathogenic mechanisms.
Future work exploring the relationship between Tregs and
neurocognition would therefore be of considerable interest.
Conclusions
The presence of endothelial dysfunction in the context of OSA
in children is strongly correlated with concomitant changes in
circulating Tregs and their function. This suggests that alterations
in Treg populations may contribute to cardiovascular morbidity in
pediatric OSA. These effects appear to be specific, and do not
seem to involve mechanisms underlying insulin resistance. The
association between Treg suppressive capacity and SPS, but not
AHI, suggests that sleep fragmentation rather than intermittent
hypoxia may be the primary perturbation affecting Tregs.
Understanding the pathophysiological mechanisms by which
OSA results in endothelial and metabolic dysfunction and the
variance in phenotype that occurs among different patients is
critical, since it would enable risk assessment and optimal
interventions in the context of more individualized medical
management. Should the decrease/down-regulation in Tregs
prove to be a crucial pathogenic pathway for the development
of endothelial dysfunction, this may present a novel therapeutic
target.
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